Paper41880378
Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.
Guan J and 3 others. PLoS One, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia. Papers, record 41880378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41880378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| TRPV Cation Channels | Major topic |
| Analgesics | Major topic |
| Inflammation | Major topic |
| Pain | Major topic |
| Urea | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Male | |
| HEK293 Cells | |
| Hyperthermia | |
| Molecular Docking Simulation |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31926897 | Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. | Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31926897 | PubMed |
| 2 | 23278358 | The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23278358 | PubMed |
| 3 | 26420335 | A pain-inducing centipede toxin targets the heat activation machinery of nociceptor TRPV1. | Nat Commun | 2015 | https://conductscience.org/library/papers/26420335 | PubMed |
| 4 | 28364279 | TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. | Protein Cell | 2017 | https://conductscience.org/library/papers/28364279 | PubMed |
| 5 | 33501656 | A plant-derived TRPV3 inhibitor suppresses pain and itch. | Br J Pharmacol | 2021 | https://conductscience.org/library/papers/33501656 | PubMed |
| 6 | 24394343 | Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis. | Contemp Clin Trials | 2014 | https://conductscience.org/library/papers/24394343 | PubMed |
| 7 | 17652633 | Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. | J Pharmacol Exp Ther | 2007 | https://conductscience.org/library/papers/17652633 | PubMed |
| 8 | 30699097 | Islet-cell autoantigen 69 mediates the antihyperalgesic effects of electroacupuncture on inflammatory pain by regulating spinal glutamate receptor subunit 2 phosphorylation through protein interacting with C-kinase 1 in mice. | Pain | 2019 | https://conductscience.org/library/papers/30699097 | PubMed |
| 9 | 17325193 | Thermosensitive TRPV channel subunits coassemble into heteromeric channels with intermediate conductance and gating properties. | J Gen Physiol | 2007 | https://conductscience.org/library/papers/17325193 | PubMed |
| 10 | 11418861 | Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. | Nature | 2001 | https://conductscience.org/library/papers/11418861 | PubMed |
| 11 | 38776567 | Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects. | Bioorg Med Chem | 2024 | https://conductscience.org/library/papers/38776567 | PubMed |
| 12 | 24861977 | TRPV1: A Potential Drug Target for Treating Various Diseases. | Cells | 2014 | https://conductscience.org/library/papers/24861977 | PubMed |
| 13 | 27537761 | A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods. | Anesth Analg | 2016 | https://conductscience.org/library/papers/27537761 | PubMed |
| 14 | 36008373 | Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects In Vivo Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core. | J Med Chem | 2022 | https://conductscience.org/library/papers/36008373 | PubMed |
| 15 | 34062143 | Chronic pain: an update on burden, best practices, and new advances. | Lancet | 2021 | https://conductscience.org/library/papers/34062143 | PubMed |
| 16 | 33359917 | Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/33359917 | PubMed |
| 17 | 21575625 | Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist. | Eur J Pharmacol | 2011 | https://conductscience.org/library/papers/21575625 | PubMed |
| 18 | 33165872 | TRPV1-Targeted Drugs in Development for Human Pain Conditions. | Drugs | 2021 | https://conductscience.org/library/papers/33165872 | PubMed |
| 19 | 25590988 | The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. | Neuroreport | 2015 | https://conductscience.org/library/papers/25590988 | PubMed |
| 20 | 18337008 | Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. | Pain | 2008 | https://conductscience.org/library/papers/18337008 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERG | 2078 | PubTator's text mining | https://conductscience.org/library/genes/2078 | NCBI Gene |
| KCNH2 | 3757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
| SCN5A | 6331 | PubTator's text mining | https://conductscience.org/library/genes/6331 | NCBI Gene |
| TRPV1 | 7442 | PubTator's text mining | https://conductscience.org/library/genes/7442 | NCBI Gene |
| TRPV2 | 51393 | PubTator's text mining | https://conductscience.org/library/genes/51393 | NCBI Gene |
| TRPV3 | 162514 | PubTator's text mining | https://conductscience.org/library/genes/162514 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41880378
GET https://conductscience.org/api/papers/v1/41880378/references?page=2